Agilent has introduced the GenetiSure Pre-Screen Kit, a high-throughput microarray for screening aneuploidy and other genomic aberrations.
Aneuploidy is a condition in which a cell contains an abnormal number of chromosomes. Extra or missing chromosomes may cause abnormalities.
Agilent’s new pre-screen kit allows for a turnaround time of less than eight hours from DNA extraction to data analysis – an industry first. GenetiSure can screen single cells in three-day and five-day embryos, run up to 14 samples simultaneously, and screen aberrations in the 5-Mb to 10-Mb range.
“No other array platform currently has this high-throughput capacity, with less than eight hours turnaround time, with this resolution,” says Dr. Richard Choy, a director and associate professor at the Chinese University of Hong Kong.
GenetiSure was developed based on a protocol designed by Dr. Ali Hellani of the Viafet Genomic Center in Dubai. The new kit utilizes Agilent’s market-leading technology for high-resolution oligonucleotide comparative genomic hybridization (CGH).
Watch this video to learn more about how Agilent’s GenetiSure Pre-Screen kit is helping today’s leading geneticists rapidly detect aneuploidy in embryos.
For Research Use Only. Not for use in diagnostic procedures.
For more information go to:
- GenetiSure Pre-Screen Kit
- Agilent Technologies Introduces Microarray for Rapid Screening of Aneuploidy in Single Cells from Embryos
- Agilent: Fast, Cost-Effective Aneuploidy Detection
- Aneuploidy
- Dr. Choy Kwong Wai (Richard), Ph.D.
- Dr. Ali Hellani, Ph.D.
- Dr. Ali Hellani e-seminar
- Agilent CGH & CGH+SNP Microarrays
